Why we need bold collaborations to transform health - a word from our director
Bold collaborations. Transforming health. This is how I described IHI when I met with Members of the European Parliament this month. All of our projects are public-private partnerships, involving universities, industry, hospitals, SMEs, patient organisations and more, and this broad participation is key to our success.
This newsletter showcases two good examples of how bold collaborations can deliver long-lasting, transformative outcomes at opposite ends of health research – from changing patient journeys to advancing the early discovery of new antivirals.
The master protocol for type 1 diabetes screening developed in the EDENT1FI project is now linked to the national screening programme for children and teenagers in Italy – directly supporting early intervention and improved outcomes for people living with diabetes.
The CARE project, launched in the emergency response to the COVID-19 pandemic, came to a close and has left an impressive legacy of open data. In addition to the compounds taken forward by project partners, the project has released 12 public datasets of screening data, supporting future data-driven approaches for antiviral response.
Niklas Blomberg, IHI Executive Director
This newsletter showcases two good examples of how bold collaborations can deliver long-lasting, transformative outcomes at opposite ends of health research – from changing patient journeys to advancing the early discovery of new antivirals.
The master protocol for type 1 diabetes screening developed in the EDENT1FI project is now linked to the national screening programme for children and teenagers in Italy – directly supporting early intervention and improved outcomes for people living with diabetes.
The CARE project, launched in the emergency response to the COVID-19 pandemic, came to a close and has left an impressive legacy of open data. In addition to the compounds taken forward by project partners, the project has released 12 public datasets of screening data, supporting future data-driven approaches for antiviral response.
Niklas Blomberg, IHI Executive Director
Bold collaborations vital for advanced health research, European Parliament committee hears
IHI’s Niklas Blomberg exchanged views with Members of the European Parliament from the Committee on Public Health (SANT) about how public-private partnerships like IHI can propel health innovation forwards.
Read more
Preparing for the next pandemic with the CARE project
IMI project CARE played a crucial role in advancing our understanding of how to treat COVID-19, and laid the groundwork for improving preparedness for future pandemics.
Italy screens for type 1 diabetes alongside EDENT1FI
The IHI EDENT1FI project is cooperating with the Italian government as new screening programmes to detect type 1 diabetes in children and teenagers are rolled out.
New immunotracers indicate whether immunotherapy will work
New tools developed by the Immune-Image project can indicate the presence of cells that inhibit immunotherapy. This could help identify people who will respond well to immunotherapy.
The AUTOPIX project: putting pictures to work for patients
People with arthritis regularly undergo scans; now a new IHI project will deliver resources to boost the usefulness of the resulting images to both patients and physicians.
In conversation with... ITCC-P4
Join us online on 24 April for an event on IMI project ITCC-P4, which delivered tools to help identify promising molecules that could form the basis of new drugs to treat childhood cancer.
IHI call deadlines approaching
The deadlines for IHI’s open calls are just weeks away – IHI call 9 on 29 April, and IHI call 10 on 23 April. Got questions? Check out our guide for applicants and FAQs, and if you have questions, ask!